Streetbeat News

Stock Prices

BVXV

BiondVax Pharmaceuticals has signed a worldwide license agreement to develop an antibody for the treatment of autoimmune and inflammatory diseases, causing its shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:45 pm

DAL

UAL

United Airlines Pilots Union has unanimously approved a vote to authorize a strike, demanding better pay than Delta Air Lines pilots. The Air Line Pilots Association has not yet set a date for the strike vote.

Portfolio Pulse from Akanksha Bakshi

June 05, 2023 | 12:43 pm

AVDX

GHL

NU

SOFI

SYF

The article lists the top 5 overbought financial stocks that may implode in Q2, including Nu Holdings, Synchrony Financial, Greenhill & Co., SoFi Technologies, and AvidXchange Holdings. These stocks have high RSI values, indicating they may be overvalued.

Portfolio Pulse from Lisa Levin

June 05, 2023 | 12:39 pm

HHC

HIBB

L

Insiders have recently purchased shares in Loews Corporation (L), The Howard Hughes Corporation (HHC), and Hibbett, Inc. (HIBB). Loews reported a Q1 2023 EPS of $1.61, up from $1.29 a year ago. Howard Hughes posted a narrower-than-expected quarterly loss, and Hibbett reported a 7.4% YoY sales growth in Q1 FY23, missing the consensus.

Portfolio Pulse from Lisa Levin

June 05, 2023 | 12:37 pm

TMBR

Timber Pharmaceuticals shares are trading higher after the FDA approved its TMB-001 treatment.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:36 pm

BA

All Nippon Airways' CEO expressed interest in expanding their fleet with more than 100 Boeing 787 planes. This could potentially lead to increased orders for Boeing.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:34 pm

COWZ

CVS

DE

PWR

CNBC's 'Halftime Report Final Trades' featured stock recommendations from various analysts. Deere & Company reported better-than-expected Q2 results, while CVS Health reaffirmed its FY23 outlook. Pacer US Cash Cows 100 ETF was cited for its exposure to energy, industrials, and materials. Quanta Services announced a new share repurchase program and declared a quarterly dividend.

Portfolio Pulse from Lisa Levin

June 05, 2023 | 12:33 pm

TMBR

The FDA has granted a dermal carcinogenicity waiver for Timber Pharmaceuticals' TMB-001, a topical isotretinoin formulated using the company's patented IPEG delivery system. This allows Timber to forgo a 2-year dermal rodent carcinogenicity study and accelerate the TMB-001 program. TMBR shares are up 87.90% at $2.80 during the premarket session.

Portfolio Pulse from Vandana Singh

June 05, 2023 | 12:31 pm

DAWN

Day One Biopharmaceuticals reported positive new data for its treatment of relapsed or progressive pediatric low-grade glioma, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 12:30 pm

AAL

DAL

LUV

UAL

Supply chain issues are expected to disrupt air travel in summer 2023, according to the International Air Transport Association. Shortages of engine parts may delay the delivery of new aircraft from manufacturers, and a shortage of air traffic control staff is also anticipated.

Portfolio Pulse from Akanksha Bakshi

June 05, 2023 | 12:30 pm